Research & Literature

Moyamoya disease and syndromes: from genetics to clinical management.

Guey S, Tournier-Lasserve E, Hervé D, Kossorotoff M

The application of clinical genetics 2015; (8()):49-68 doi:10.2147/TACG.S42772.

Diagnosis of moyamoya disease: international standard and regional differences.

Fujimura M, Tominaga T

Neurologia medico-chirurgica 2015; (55(3)):189-93 doi:10.2176/nmc.ra.2014-0307.

Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.

Kuhn FP, Warnock G, Schweingruber T, et al.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2015; (24(5)):965-71.

Current status of revascularization surgery for Moyamoya disease: special consideration for its 'internal carotid-external carotid (IC-EC) conversion' as the physiological reorganization system.

Fujimura M, Tominaga T

The Tohoku journal of experimental medicine 2015; (236(1)):45-53 doi:10.1620/tjem.236.45.

Research Progress of Moyamoya Disease in Children.

Piao J, Wu W, Yang Z, Yu J

International journal of medical sciences 2015; (12(7)):566-75 doi:10.7150/ijms.11719.

Moyamoya Syndrome: A Window of Moyamoya Disease.

Phi JH, Wang KC, Lee JY, Kim SK

Journal of Korean Neurosurgical Society 2015; (57(6)):408-14 doi:10.3340/jkns.2015.57.6.408.

Significance of Cerebral Blood Flow Analysis in the Acute Stage after Revascularization Surgery for Moyamoya Disease.

Fujimura M, Tominaga T

Neurologia medico-chirurgica 2015; (55(10)):775-81 doi:10.2176/nmc.ra.2015-0063.

A new horizon of moyamoya disease and associated health risks explored through RNF213.

Koizumi A, Kobayashi H, Hitomi T, et al.

Environmental health and preventive medicine 2016; (21(2)):55-70 doi:10.1007/s12199-015-0498-7.

Long term outcome and predictors of ischemic stroke recurrence in adult moyamoya disease.

Noh HJ, Kim SJ, Kim JS, et al.

Journal of the neurological sciences 2015; (359(1-2)):381-8.

Moyamoya Disease: Epidemiology, Clinical Features, and Diagnosis.

Kim JS

Journal of stroke 2016; (18(1)):2-11 doi:10.5853/jos.2015.01627.

Cerebrovascular Events During Pregnancy and Puerperium Resulting from Preexisting Moyamoya Disease: Determining the Risk of Ischemic Events Based on Hemodynamic Status Assessment Using Brain Perfusion Single-Photon Emission Computed Tomography.

Lee SU, Chung YS, Oh CW, et al.

World neurosurgery 2016; (90()):66-75 doi:10.1016/j.wneu.2016.02.062.

Added Value of Vessel Wall Magnetic Resonance Imaging in the Differentiation of Moyamoya Vasculopathies in a Non-Asian Cohort.

Mossa-Basha M, de Havenon A, Becker KJ, et al.

Stroke 2016; (47(7)):1782-8 doi:10.1161/STROKEAHA.116.013320.

Clinical Features and Long-Term Outcomes of Unilateral Moyamoya Disease.

Zhang Q, Wang R, Liu Y, et al.

World neurosurgery 2016; (96()):474-482 doi:10.1016/j.wneu.2016.09.018.

Revascularization of Moyamoya Angiopathy in Older Adults.

Williamson RW, Abla AA, Zabramski JM, et al.

World neurosurgery 2017; (99()):37-40 doi:10.1016/j.wneu.2016.11.073.

Moyamoya Disease in Children: Results From the International Pediatric Stroke Study.

Lee S, Rivkin MJ, Kirton A, et al.

Journal of child neurology 2017; (32(11)):924-929 doi:10.1177/0883073817718730.

Rare variants of RNF213 and moyamoya/non-moyamoya intracranial artery stenosis/occlusion disease risk: a meta-analysis and systematic review.

Liao X, Deng J, Dai W, et al.

Environmental health and preventive medicine 2017; (22(1)):75 doi:10.1186/s12199-017-0680-1.

Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Moyamoya Disease: Region-Symptom Mapping and Estimating a Critical Threshold.

Kazumata K, Uchino H, Tokairin K, et al.

World neurosurgery 2018; (114()):e388-e395 doi:10.1016/j.wneu.2018.02.190.

Longitudinal anterior-to-posterior shift of collateral channels in patients with moyamoya disease: an implication for its hemorrhagic onset.

Yamamoto S, Hori S, Kashiwazaki D, et al.

Journal of neurosurgery 2019; (130(3)):884-890 doi:10.3171/2017.9.JNS172231.

Late Cerebrovascular Events and Social Outcome after Adolescence: Long-term Outcome of Pediatric Moyamoya Disease.

Funaki T, Takahashi JC, Miyamoto S

Neurologia medico-chirurgica 2018; (58(6)):240-246 doi:10.2176/nmc.ra.2018-0026.

Accuracy of brain perfusion single-photon emission computed tomography for detecting misery perfusion in adult patients with symptomatic ischemic moyamoya disease.

Setta K, Kojima D, Shimada Y, et al.

Annals of nuclear medicine 2018; (32(9)):611-619 doi:10.1007/s12149-018-1283-7.

Long-Term Neurocognitive Outcomes in Patients with Adult Moyamoya Disease.

Nakamizo A, Amano T, Michiwaki Y, et al.

World neurosurgery 2018; (119()):e441-e448 doi:10.1016/j.wneu.2018.07.179.

Trends of Antiplatelet Therapy for the Management of Moyamoya Disease in Japan: Results of a Nationwide Survey.

Oki K, Katsumata M, Izawa Y, et al.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2018; (27(12)):3605-3612 doi:10.1016/j.jstrokecerebrovasdis.2018.08.030.

Cognitive Functions in Children and Adults with Moyamoya Vasculopathy: A Systematic Review and Meta-Analysis.

Kronenburg A, van den Berg E, van Schooneveld MM, et al.

Journal of stroke 2018; (20(3)):332-341 doi:10.5853/jos.2018.01550.

Epidemiology of Moyamoya Disease in China: Single-Center, Population-Based Study.

Bao XY, Wang QN, Zhang Y, et al.

World neurosurgery 2019; (122()):e917-e923 doi:10.1016/j.wneu.2018.10.175.

Childhood Moyamoya: Looking Back to the Future.

Dlamini N, Muthusami P, Amlie-Lefond C

Pediatric neurology 2019; (91()):11-19 doi:10.1016/j.pediatrneurol.2018.10.006.

Superficial temporal artery-to-middle cerebral artery bypass in combination with indirect revascularization in moyamoya patients ≤ 3 years of age.

Bot GM, Burkhardt JK, Gupta N, Lawton MT

Journal of neurosurgery. Pediatrics 2019; (23(2)):198-203.

Time Course of Neoangiogenesis After Indirect Bypass Surgery for Moyamoya Disease : Comparison of Short-term and Long-term Follow-up Angiography.

Zhao Y, Lu J, Zhang Q, et al.

Clinical neuroradiology 2020; (30(1)):91-99 doi:10.1007/s00062-018-0748-3.

Imaging of Moyamoya Disease and Moyamoya Syndrome: Current Status.

Li J, Jin M, Sun X, et al.

Journal of computer assisted tomography 2019; (43(2)):257-263 doi:10.1097/RCT.0000000000000834.

Direct Bypass Surgery Vs. Combined Bypass Surgery for Hemorrhagic Moyamoya Disease: A Comparison of Angiographic Outcomes.

Zhao Y, Yu S, Lu J, et al.

Frontiers in neurology 2018; (9()):1121 doi:10.3389/fneur.2018.01121.

Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [15O]-Water Positron Emission Tomography/Magnetic Resonance Imaging Normative Database.

Fan AP, Khalighi MM, Guo J, et al.

Stroke 2019; (50(2)):373-380 doi:10.1161/STROKEAHA.118.023426.

Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.

Quon JL, Kim LH, Lober RM, et al.

Journal of neurosurgery. Pediatrics 2019; (23(4)):486-492 doi:10.3171/2018.11.PEDS18498.

Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.

Ishii Y, Thamm T, Guo J, et al.

Journal of magnetic resonance imaging : JMRI 2020; (51(1)):183-194 doi:10.1002/jmri.26773.

Incidence and Risk Factors of the Watershed Shift Phenomenon after Superficial Temporal Artery-Middle Cerebral Artery Anastomosis for Adult Moyamoya Disease.

Tashiro R, Fujimura M, Kameyama M, et al.

Cerebrovascular diseases (Basel, Switzerland) 2019; (47(3-4)):178-187 doi:10.1159/000500802.

Superficial temporal artery-middle cerebral artery anastomosis patency correlates with cerebrovascular reserve in adult moyamoya syndrome patients.

Aboukais R, Verbraeken B, Leclerc X, et al.

Neuro-Chirurgie 2019; (65(4)):146-151 doi:10.1016/j.neuchi.2019.05.001.

Surgical outcomes for pediatric moyamoya: a systematic review and meta-analysis.

Ravindran K, Wellons JC, Dewan MC

Journal of neurosurgery. Pediatrics 2019; (24(6)):663-672 doi:10.3171/2019.6.PEDS19241.

Angiographic Analysis of Natural Anastomoses between the Posterior and Anterior Cerebral Arteries in Moyamoya Disease and Syndrome.

Bonasia S, Ciccio G, Smajda S, et al.

AJNR. American journal of neuroradiology 2019; (40(12)):2066-2072 doi:10.3174/ajnr.A6291.

Cerebral Hyperperfusion Syndrome After Revascularization Surgery in Patients with Moyamoya Disease: Systematic Review and Meta-Analysis.

Yu J, Zhang J, Li J, et al.

World neurosurgery 2020; (135()):357-366.e4 doi:10.1016/j.wneu.2019.11.065.

Postoperative change of neuropsychological function after indirect revascularization in childhood moyamoya disease: a correlation with cerebral perfusion study.

Hsu YH, Chen YF, Yang SH, et al.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2020; (36(6)):1245-1253 doi:10.1007/s00381-019-04432-5.

Predicting Ischemic Risk Using Blood Oxygen Level-Dependent MRI in Children with Moyamoya.

Dlamini N, Slim M, Kirkham F, et al.

AJNR. American journal of neuroradiology 2020; (41(1)):160-166 doi:10.3174/ajnr.A6324.

Impact of Endothelial Shear Stress on the Bilateral Progression of Unilateral Moyamoya Disease.

Lee WJ, Jeong SK, Han KS, et al.

Stroke 2020; (51(3)):775-783 doi:10.1161/STROKEAHA.119.028117.

Late (5-20 years) outcomes after STA-MCA anastomosis and encephalo-duro-myo-arterio-pericranial synangiosis in patients with moyamoya disease.

Kuroda S, Nakayama N, Yamamoto S, et al.

Journal of neurosurgery 2021; (134(3)):909-916 doi:10.3171/2019.12.JNS192938.

Assessment of Transient Cerebral Hemodynamic Disturbance via Whole-Brain Computed Tomography Perfusion After Extracranial-Intracranial Bypass in Ischemic Moyamoya Disease.

Yao F, Han Q, Zhang Z, Huang Y

World neurosurgery 2021; (146()):e112-e121 doi:10.1016/j.wneu.2020.10.046.

Moyamoya Disease Associated with Graves' Disease and Down Syndrome: A Case Report and Literature Review.

Nakamura H, Sato K, Yoshimura S, et al.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association 2021; (30(1)):105414 doi:10.1016/j.jstrokecerebrovasdis.2020.105414.

Moyamoya: An Update and Review.

Berry JA, Cortez V, Toor H, et al.

Cureus 2020; (12(10)):e10994 doi:10.7759/cureus.10994.

Cutaneous manifestations in Moyamoya angiopathy: A review.

Mitri F, Bersano A, Hervé D, Kraemer M

European journal of neurology 2021; (28(5)):1784-1793 doi:10.1111/ene.14754.

Efficacy and Safety of Antiplatelet Agents for Adult Patients With Ischemic Moyamoya Disease.

Ye F, Li J, Wang T, et al.

Frontiers in neurology 2020; (11()):608000 doi:10.3389/fneur.2020.608000.

Current trends in pediatric moyamoya: a survey of international practitioners.

Srinivasan HL, Hausman-Kedem M, Smith ER, et al.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2021; (37(6)):2011-2023 doi:10.1007/s00381-021-05074-2.

Seizure outcome in moyamoya after indirect revascularization in pediatric patients: Retrospective study and literature review.

Alramadan A, Ul Haq A, Basindwah S, Alshail E

Surgical neurology international 2021; (12()):73 doi:10.25259/SNI_633_2020.

Early manifestation of Moyamoya syndrome in a 2-year-old child with Down syndrome.

Tajmalzai A, Shirzai A, Najah DM

Radiology case reports 2021; (16(7)):1740-1744 doi:10.1016/j.radcr.2021.04.017.

The angiographic presentation of European Moyamoya angiopathy.

Pilgram-Pastor S, Chapot R, Kraemer M

Journal of neurology 2022; (269(2)):997-1006 doi:10.1007/s00415-021-10684-6.

Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Zhang X, Xiao W, Zhang Q, et al.

Current neuropharmacology 2022; (20(2)):292-308 doi:10.2174/1570159X19666210716114016.

Clinical Management of Moyamoya Patients.

Canavero I, Vetrano IG, Zedde M, et al.

Journal of clinical medicine 2021; (10(16)) doi:10.3390/jcm10163628.

Pathophysiology of Vascular Stenosis and Remodeling in Moyamoya Disease.

Fox BM, Dorschel KB, Lawton MT, Wanebo JE

Frontiers in neurology 2021; (12()):661578 doi:10.3389/fneur.2021.661578.

Moyamoya angiopathy in a case of Klinefelter syndrome.

Ghosh R, Das S, Roy D, et al.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2022; (38(6)):1195-1199 doi:10.1007/s00381-021-05371-w.

Evaluation and treatment of headache associated with moyamoya disease - a narrative review.

Chiang CC, Shahid AH, Harriott AM, et al.

Cephalalgia : an international journal of headache 2022; (42(6)):542-552 doi:10.1177/03331024211056250.

Moyamoya Vasculopathy: Cause, Clinical Manifestations, Neuroradiologic Features, and Surgical Management.

Velo M, Grasso G, Fujimura M, et al.

World neurosurgery 2022; (159()):409-425 doi:10.1016/j.wneu.2021.11.026.

The neurosurgical management of Severe Hemophilia A and Moyamoya (SHAM): challenges, strategies, and literature review.

Xu R, Kalluri AL, Sun LR, et al.

Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery 2022; (38(6)):1077-1084 doi:10.1007/s00381-022-05489-5.

Fronto-Parietal and White Matter Haemodynamics Predict Cognitive Outcome in Children with Moyamoya Independent of Stroke.

Choi EJ, Westmacott R, Kirkham FJ, et al.

Translational stroke research 2022; (13(5)):757-773 doi:10.1007/s12975-022-01003-w.

Pediatric Moyamoya Disease and Syndrome in Italy: A Multicenter Cohort.

Po' C, Nosadini M, Zedde M, et al.

Frontiers in pediatrics 2022; (10()):892445 doi:10.3389/fped.2022.892445.

Moyamoya disease: diagnosis and interventions.

Ihara M, Yamamoto Y, Hattori Y, et al.

The Lancet. Neurology 2022; (21(8)):747-758 doi:10.1016/S1474-4422(22)00165-X.

Diagnostic Criteria for Moyamoya Disease - 2021 Revised Version.

Kuroda S, Fujimura M, Takahashi J, et al.

Neurologia medico-chirurgica 2022; (62(7)):307-312 doi:10.2176/jns-nmc.2022-0072.

Revascularization improves vascular hemodynamics - a study assessing cerebrovascular reserve and transit time in Moyamoya patients using MRI.

Zhao MY, Armindo RD, Gauden AJ, et al.

Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism 2023; (43(2_suppl)):138-151 doi:10.1177/0271678X221140343.

Morning glory disc anomaly and its implications in moyamoya arteriopathy: a retrospective case series.

See AP, LoPresti MA, Treiber J, et al.

Journal of neurosurgery. Pediatrics 2023; 1-7 doi:10.3171/2023.2.PEDS22470.

Potential predictors for progression of moyamoya disease: A systematic review and meta-analysis.

Cao J, Xing Z, Dai L, et al.

Frontiers in neurology 2023; (14()):1128338 doi:10.3389/fneur.2023.1128338.

Pragmatic anesthetic approach for extracranial to intracranial bypass surgery in a patient with moyamoya disease and sickle cell disease: a case report.

Lal S, Larney V

Journal of medical case reports 2023; (17(1)):136 doi:10.1186/s13256-023-03857-6.

European Stroke Organisation (ESO) Guidelines on Moyamoya angiopathy Endorsed by Vascular European Reference Network (VASCERN).

Bersano A, Khan N, Fuentes B, et al.

European stroke journal 2023; (8(1)):55-84 doi:10.1177/23969873221144089.

Idiopathic steno-occlusive disease with bilateral internal carotid artery occlusion: A Case Report.

Hamed SA, Yousef HA

World journal of clinical cases 2023; (11(13)):3076-3085 doi:10.12998/wjcc.v11.i13.3076.

[Variants of collateral cerebral circulation in moyamoya disease].

Shulgina AA, Lukshin VA, Usachev DY

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 2023; (87(3)):20-28 doi:10.17116/neiro20238703120.

The diagnostic performance of high-resolution magnetic resonance-vessel wall imaging in differentiating atherosclerosis-associated moyamoya vasculopathy from moyamoya disease.

Liu S, Lu M, Gao X, et al.

European radiology 2023; (33(10)):6918-6926 doi:10.1007/s00330-023-09951-z.

Pediatric Moyamoya Revascularization Perioperative Care: A Modified Delphi Study.

Sun LR, Jordan LC, Smith ER, et al.

Neurocritical care 2024; (40(2)):587-602 doi:10.1007/s12028-023-01788-0.

Post-Surgical Cognitive Outcomes of Moyamoya Disease: A Systematic Review.

Mitchell DL, Shlobin NA, LoPresti MA, et al.

World neurosurgery 2023; (178()):181-190.e1 doi:10.1016/j.wneu.2023.07.099.

Prevalence and Associations of Cognitive Impairment in Adult Patients with Moyamoya Disease: A Systematic Review and Meta-Analysis.

Toh KZX, Koh MY, Loh EDW, et al.

Journal of Alzheimer's disease : JAD 2024; (97(2)):541-552 doi:10.3233/JAD-230979.

Health-Related Quality of Life and Neuropsychological Outcome After EC-IC Bypass Revascularization in Adult Patients With Moyamoya Disease.

Haas P, Kittelberger BB, Hurth H, et al.

Neurosurgery 2024; (94(6)):1107-1115 doi:10.1227/neu.0000000000002813.

MRI hypoperfusion as a determinant of cognitive impairment in adults with Moyamoya angiopathy.

Giroud M, Planton M, Darcourt J, et al.

European stroke journal 2024; (9(3)):732-742 doi:10.1177/23969873241240829.

Neuropsychiatric Symptoms of Moyamoya Disease: Considerations for the Clinician.

Oakley CI, Lanzino G, Klaas JP

Neuropsychiatric disease and treatment 2024; (20()):663-669 doi:10.2147/NDT.S440975.

Stroke and Disease Progression During Long-Term Follow-Up of Patients with Moyamoya Disease Older Than 50 Years.

Sakai R, Hara S, Inaji M, et al.

World neurosurgery 2024; (187()):e898-e907 doi:10.1016/j.wneu.2024.05.008.

A Rare Case of Cardiac Myxoma With Moyamoya Phenomenon: A Disease or Syndrome?

Konduru RA, Prasad A, Cheriyath P, Okere A

Cureus 2024; (16(4)):e59381 doi:10.7759/cureus.59381.

Neuropsychological Test Performance Differentiates Subgroups of Individuals With Adult Moyamoya Disease: A Cross-Sectional Clinical Study.

DeDios-Stern SL, Gotra MY, Resch ZJ, et al.

Neurosurgery 2024; (95(6)):1338-1348 doi:10.1227/neu.0000000000003010.

Update on the anesthesia management in adult patients with moyamoya disease.

Yang KJ, Mistry P, Ayrian E

Current opinion in anaesthesiology 2024; (37(5)):439-445 doi:10.1097/ACO.0000000000001411.

Adult Moyamoya Disease and Moyamoya Syndrome: What Is New?

Uchiyama S, Fujimura M

Cerebrovascular diseases extra 2024; (14(1)):86-94 doi:10.1159/000540254.

Magnetic Resonance Angiography Alone Is Insufficient for Diagnosis and Surgical Planning in Children With Moyamoya.

Lehman LL, Wu C, Kaseka ML, et al.

Pediatric neurology 2024; (159()):1-3 doi:10.1016/j.pediatrneurol.2024.06.008.

Superficial Temporal Artery Size Changes After Encephaloduroarteriosynangiosis for the Treatment of Moyamoya Disease.

McNeil E, Enriquez-Marulanda A, Ramirez Velandia F, et al.

World neurosurgery 2024; (190()):e774-e780 doi:10.1016/j.wneu.2024.07.217.

Moyamoya Disease: A Rare Presentation and Literature Review.

Bagchi AS, Hore P, Mandal S, Pal SK

The Journal of the Association of Physicians of India 2024; (72(8)):86-88 doi:10.59556/japi.72.0580.

Case Report: A rare presentation of rapidly progressive moyamoya disease refractory to unilateral surgical revascularization.

Leach DF, Margam S, Gustin A, et al.

Frontiers in surgery 2024; (11()):1409692 doi:10.3389/fsurg.2024.1409692.

Is initial unilateral revascularization acceptable in pediatric patients with bilateral moyamoya disease with mild contralateral hemodynamic disturbance?

Kuroha M, Hara S, Fujioka M, et al.

Journal of neurosurgery. Pediatrics 2024; (34(6)):574-584 doi:10.3171/2024.7.PEDS23550.

Pseudo-continuous and territorial arterial spin labeling MRI for assessment of cerebral perfusion in moyamoya disease after revascularization: A comparative study with digital subtraction angiography.

Li J, Meng Q, Huang L, et al.

Heliyon 2024; (10(17)):e37368 doi:10.1016/j.heliyon.2024.e37368.

HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K.

Xu J, Zou Z, Liu W, et al.

European journal of neurology 2024; (31(12)):e16473 doi:10.1111/ene.16473.

Clinical Characteristics and Multi-Model Imaging Analysis of Moyamoya Disease: An Observational Study.

Ling H, Huang H, Fu B, et al.

The Journal of craniofacial surgery 2025; (36(1)):e45-e49 doi:10.1097/SCS.0000000000010765.

The Impact of Revascularization Surgery on Headaches in Association with Cerebrovascular Reactivity in Patients with Moyamoya Angiopathy.

Gallego Moyano FD, Janssen HC, Venkatraghavan L, et al.

Brain sciences 2024; (14(10)) doi:10.3390/brainsci14100967.

Autoregulatory dysfunction in adult Moyamoya disease with cerebral hyperperfusion syndrome after bypass surgery.

Kim JH, Hong N, Kim H, et al.

Scientific reports 2024; (14(1)):26451 doi:10.1038/s41598-024-76559-8.

Effects of Scalp Nerve Block on Symptomatic Cerebral Hyperperfusion Syndrome After Combined Revascularization Surgery for Moyamoya Disease.

Choi S, Park JY, Jo WY, et al.

Journal of neurosurgical anesthesiology 2026; (38(1)):81-86 doi:10.1097/ANA.0000000000001024.

Moyamoya Across the Lifespan: Current Neurologic Care and Future Directions.

Sun LR, Vossough A, Kossorotoff M, et al.

Neurology 2025; (104(7)):e213484 doi:10.1212/WNL.0000000000213484.

Safety analysis of STA-MCA bypass combined with EDAS in the treatment of patients with moyamoya disease.

Zhu C, Wang Y, Li J

Medicine 2025; (104(12)):e41769 doi:10.1097/MD.0000000000041769.

Psychological outcomes and health-related quality of life changes in Chinese patients with moyamoya disease after revascularization.

Liang H, Yuan P, Xu T, et al.

Frontiers in surgery 2025; (12()):1573992 doi:10.3389/fsurg.2025.1573992.

Ultrasonographic assessment of bypass capacity after revascularization surgery in moyamoya disease: a systematic review and single-arm meta-analysis.

Koc NA, Rakowski M, Pettersson SD, et al.

Acta neurochirurgica 2025; (167(1)):242 doi:10.1007/s00701-025-06658-6.

The Spectrum of Headaches in Moyamoya Angiopathy: From Mechanisms to Management Strategies-A Consensus Review From the NEUROVASC Working Group.

Rifino N, Aamodt AH, Wiedmann M, et al.

European journal of neurology 2025; (32(10)):e70316 doi:10.1111/ene.70316.

Moyamoya Disease: Pathophysiology, Diagnosis, and Treatment.

Mertens R, Siebert E, Endres M, et al.

Deutsches Arzteblatt international 2025; (122(26)):722-728.

[Epilepsy in Patients With Moyamoya Angiopathy].

Bautista-Lacambra M, Garayoa-Irigoyen V, Tique-Rojas LF, et al.

Revista de neurologia 2025; (80(9)):37504 doi:10.31083/RN37504.

Indirect Revascularization for Pediatric Moyamoya Angiopathy: Insights from a Brazilian Cohort.

Savoldi AM, Demartini Z, Cordeiro ML

Journal of clinical medicine 2025; (14(21)) doi:10.3390/jcm14217739.

Assessment of cerebrovascular reserve using acetazolamide brain perfusion SPECT in Moyamoya disease.

Goyal H, Chakraborty D, Kumar SA, Pandey S

Asia Oceania journal of nuclear medicine & biology 2026; (14(1)):90-97 doi:10.22038/aojnmb.2025.89265.1647.

Thyrotoxicosis and Moyamoya Syndrome: A Fatal Intersection of Rare Disorders in a Young Patient With a Background of Hypothyroidism.

Abu Rabia H

Cureus 2026; (18(1)):e100852 doi:10.7759/cureus.100852.

Non-aneurysmal Subarachnoid Hemorrhage in an Adult With Sickle Cell Anemia: A Case Report and Review of the Literature.

Okal FM, AlSindi T, AlHarbi NF, Bajunaid KM

Cureus 2026; (18(1)):e101929 doi:10.7759/cureus.101929.

A novel superficial temporal artery patency concept of cerebral revascularization for patients with moyamoya disease: a multicenter study.

Shi Z, Li X, Chen X, et al.

Chinese neurosurgical journal 2026; (12(1)).

Neurological Complications in Children with Moyamoya Disease-Case Report and Literature Review.

Grigore I, Butnariu LI, Schreiner TG, et al.

Journal of clinical medicine 2026; (15(6)) doi:10.3390/jcm15062242.

Imaging-Based Diagnostic Approaches in Moyamoya Disease: A Scoping Review.

Novillo-Solis C, Salvador-Orbea M, Morales-Acosta A, Leon-Rojas JE

Journal of clinical medicine 2026; (15(6)) doi:10.3390/jcm15062410.

Limb-shaking transient ischemic attack progressing to cerebral infarction in moyamoya angiopathy: case report.

Li C, Mu S, Tao T

BMC neurology 2026; (26(1)).

Dystonia as the Initial Manifestation of Moyamoya Disease: A Case Report and Literature Review.

Han S, Zhang H

Case reports in neurology 2026; (18(1)):193-201 doi:10.1159/000551321.

Clinical Efficacy of Revascularization Surgery for Moyamoya Angiopathy: Long-Term Results of a European Cohort.

Mertens R, Efe I, Mrosk F, et al.

European journal of neurology 2026; (33(6)):e70664 doi:10.1111/ene.70664.